Lucid Group (LCID) recently announced its second-quarter earnings, showing a year-over-year increase in sales to $259 million and a decrease in net loss to $539 million. Despite these improvements, ...

Wall Street logged its best week since late June, rebounding from a weak July jobs report on Monday and boosted by strong ...

Lucid posted deeper Q2 losses and cut its 2025 outlook, but strong liquidity and a key Uber deal support long-term growth.

Lucid Group’s stock has experienced a notable decline of 11.62% over the past week, reflecting a challenging period for the electric vehicle manufacturer. The company’s recent earnings report ...

BTIG analyst Thomas Shrader maintained a Hold rating on Inmune Bio ( INMB – Research Report) yesterday. The company’s shares closed yesterday at $2.31. Take advantage of TipRanks Premium at 50% off!

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...